Skip to content

Cognitive Recovery After Post Stroke Delirium (RECOVER)

Cognitive Recovery After Post Stroke Delirium [RECOVER] a Longitudinal Pilot Proof of Concept Study in Stroke Patients With/without Delirium

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06680336
Acronym
RECOVER
Enrollment
40
Registered
2024-11-08
Start date
2023-12-01
Completion date
2025-11-30
Last updated
2024-11-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cognitive Functioning After Stroke, Post Stroke Delirium

Brief summary

RECOVER is a Proof-of-Concept study on cognitive functioning following a longitudinal design with three measurements (during the acute- and post-acute phases of a stroke and a 3-month follow-up) and two equally-sized stroke patient groups: a post-stroke delirium(PSD), and a non-PSD group (control group). Cognitive functioning will be assessed using a multi-component neuropsychological assessment and tasked-based functional MRI (introducing a modified working memory task).

Interventions

DIAGNOSTIC_TESTMulit-componant neuropsychological assessment

Multi-component cognitive assessment including following domains: attention & information speed, executive functioning, verbal memory, language, visuospatial-construction and orientation.

DIAGNOSTIC_TESTMultimodal MRI

Structural MRI (e.g., MPRAGE, DTI) and functional MRI (introducing a modified working memory task for stroke patients)

Sponsors

University Hospital Tuebingen
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Intervention model description

Longitudinal study with 3 measurements (S1, S2, S3) and two groups of stroke patients (post-stroke-delirium (PSD) patients, non PSD patients)

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥ 60 years * Ischemic stroke: Stroke Onset ≤ 96h, hospital admission ≤ 48h * NIHSS ≥ 1 * Informed consent by patient or legal guardian

Exclusion criteria

* Aphasia * Pre-existing conditions such as Dementia, psychiatric disorders (e.g., Depression, Schizophrenia) * MRI contraindication such as certain metal implants * Reduced consciousness, defined as Glasgow Coma Scale (GCS) ≤ 8 * Delirium onset before study enrollment

Design outcomes

Primary

MeasureTime frameDescription
Global post-stroke cognitive functioning90 daysThe primary endpoint will be a between-group comparison of the cognitive outcome, defined as global post-stroke cognitive functioning, at 3 months follow-up (S3), using multimodal data generated from the neuropsychological assessment and tasked-based fMRI.

Secondary

MeasureTime frameDescription
Domain specific post-stroke cognitive functioning90 daysThe second endpoint will be a between-group comparison of the cognitive outcome, defined as domain specific post-stroke cognitive functioning, at 3 months follow-up, using multimodal data generated from the neuropsychological assessment and tasked-based fMRI.
Prediction of global post-stroke cognitive outcome5 - 90 daysA multivariate linear regression model will be used to establish a multi-item prognostic or predictive tool for cognitive outcome, defined as global post-stroke cognitive functioning at the follow-up measurement (S3) by parameters assessed at S1.

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026